文献速递肾小球疾病

资源有限地区肾小球疾病诊断与管理的挑战

Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings.
PubMed 文献 · Kidney Int Rep · 2022-07-16

该横断面网络调查通过学会邮件列表在亚洲、非洲和东欧的肾脏病专科医生中开展,共纳入33个国家的298名肾脏病照护专家,收集其人口学信息、肾活检开展与判读能力、辅助检查可及性及治疗实践。结果显示,85%的受访者开展肾活检,约61%的受访者在超过50%的可疑肾小球疾病患者中无法获取肾活检,非洲资源受限较亚洲更为突出,主要障碍包括就诊延迟、诊断检查不完整和治疗费用高昂。

要点

  • 298名来自33个国家的肾脏病照护专家参与调查,85%开展肾活检。
  • 约61%的受访者在超过50%的可疑肾小球疾病患者中无法获取肾活检。
  • 非洲约43%的受访者仅能使用光学显微镜,免疫抑制经验性使用非洲高于亚洲。

核心结论

  • 资源有限国家存在重大系统层面障碍,阻碍肾小球疾病诊断和治疗指南驱动方法的实施。

研究设计与样本

  • 横断面网络调查,通过学会邮件列表在亚洲、非洲和东欧国家的肾脏病专科医生中逐级发放。
  • 共纳入33个国家的298名肾脏病照护专家,其中53.3%来自亚洲、44.6%来自非洲,64%来自学术或大学医院。

主要发现

  • 85%的受访者开展肾活检,约61%的受访者在超过50%的可疑肾小球疾病患者中无法获取肾活检。
  • 非洲约43%的受访者仅能使用光学显微镜。
  • 无法开展和全面评估肾活检及进行辅助检查的情况在非洲比亚洲更为突出。
  • 59%的参与者报告其超过75%的患者通过自付费用支付诊断和治疗费用。
  • 免疫抑制的经验性使用非洲高于亚洲,主要障碍包括就诊延迟、诊断检查不完整和治疗费用高昂。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Glomerular diseases are the leading drivers of nondiabetic chronic kidney disease disability-adjusted life years in resource-limited countries. Proper diagnosis and treatment relies on resources including kidney biopsy, ancillary testing, and access to evidence-based therapies. METHODS: We conducted a cross-sectional internet-based survey cascaded through society mailing lists among nephrologists in countries of Asia, Africa, and Eastern Europe. We collected the data on respondent demographics, their ability to perform and appropriately interpret a kidney biopsy, and their access to complementary investigations and treatment practices. RESULTS: A total of 298 kidney care specialists from 33 countries (53.3% from Asia and 44.6% from Africa; 64% from academic or university hospitals) participated in the survey. Of these specialists, 85% performed kidney biopsy. About 61% of the respondents could not obtain a kidney biopsy in more than 50% of patients with suspected glomerular disease. About 43% of the respondents from Africa had access to only light microscopy. Overall, the inability to undertake and fully evaluate a biopsy and perform ancillary investigations were more profound in Africa than in Asia. Overall, 59% of participants reported that more than 75% of their patients meet the cost of diagnosis and treatment by out-of-pocket payments. Empirical use of immunosuppression was higher in Africa than in Asia. The main barriers for diagnosis and treatment included delayed presentation, incomplete diagnostic work-up, and high cost of treatment. CONCLUSION: Major system-level barriers impede the implementation of guideline-driven approaches for diagnosis and treatment of patients with glomerular disease in resource-limited countries.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ramachandran R, Sulaiman S, Chauhan P, et al. Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings. Kidney Int Rep. 2022. PMID: 36217525. doi:10.1016/j.ekir.2022.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。